Originally published In Press as doi:10.1074/jbc.M201251200 on May 30, 2002
J. Biol. Chem., Vol. 277, Issue 32, 28700-28705, August 9, 2002
Promoter/Origin Structure of the Complementary Strand of
Hepatitis C Virus Genome*
Takahito
Kashiwagi
,
Koyu
Hara
,
Michinori
Kohara§,
Jun
Iwahashi
,
Nobuyuki
Hamada
,
Haruhito
Honda-Yoshino
, and
Tetsuya
Toyoda
¶
From the
Department of Virology, Kurume University,
School of Medicine, 67 Asahimachi, Kurume, Fukuoka 830-0011 and the
§ Department of Microbiology and Cell Biology, Tokyo
Metropolitan Institute of Medical Biology, 3-18-22 Honkomagome,
Bunkyo-Ku, Tokyo 113-8613, Japan
Received for publication, February 6, 2002, and in revised form, May 24, 2002
 |
ABSTRACT |
Hepatitis C virus (HCV) NS5B protein encodes an
RNA-dependent RNA polymerase (RdRp). Sequences in the 3'
termini of both the plus and minus strand of HCV genomic RNA harbor the
activity of a replication origin and a transcription promoter. There
are unique stem-loop structures in both termini of the viral RNA. We
found that the complementary strand of the internal ribosome-binding site (IRES) showed strong template activity in vitro. The
complementary strand RNA of the HCV genome works as a template for
mRNA and viral genomic RNA. We analyzed the promoter/origin
structure of the complementary sequence of IRES and found that the
first and second stem-loops worked as negative and positive elements in RNA synthesis, respectively. The complementary strand of the second stem-loop of IRES was an important element also for binding to HCV
RdRp.
 |
INTRODUCTION |
Hepatitis C virus (HCV)1 has
a positive-stranded RNA genome and belongs to the family
Flaviviridae (1). HCV is a major causative agent of
post-transfusion sporadic non-A and non-B hepatitis worldwide (2). The
HCV RNA genome is about 9.6 kb and has a long open reading frame
encoding a polyprotein of ~3,010 amino acids (3, 4), which is
processed into at least 10 polypeptides
(NH2-C-E1-E2-p7-NS2-NS3-NS4A-NS4B-NS5A-NS5B-COOH) by host
and viral proteases (5-7). The 5'-untranslated region (UTR) contains
the highly conserved internal ribosome entry site (IRES) of 341 nucleotides (8-10). The 3'-UTR contains a polypyrimidine "U/C"
tract, a variable region, and a highly conserved 98-base X region (11,
12). The X region and polypyrimidine U/C tract are required for
viral infectivity (13). HCV RNA-dependent RNA polymerase
(RdRp) binds the X region and is important for minus strand RNA
synthesis (14-17).
NS5B shows RdRp activity in vitro (16, 18-24). NS5B has a
highly hydrophobic 21-amino acid sequence in its C terminus, and when
it is removed NS5B becomes soluble (25-27). HCV RdRp exhibits de
novo and copy-back initiation activities (18, 24, 28, 29). It can
utilize single-stranded RNA as a template but not double-stranded RNA
(30, 31). It prefers a cytidine at the 3' terminus of the template, and
de novo initiation in vitro by HCV RdRp was
selectively activated by a high GTP concentration (22, 23, 26, 30, 32).
It can utilize both viral and non-viral RNA templates although a
specific promoter has not been identified (18, 22, 24). NS5B bound to
the poly(U) stretch (18) and the upstream conserved stem-loop
structures at the 3' end of the genome (14). We have recently found
that the complementary sequence of IRES showed very strong template
activity (26, 34).
In this study, we analyzed the promoter/origin structure of the
complementary sequence of IRES, and we determined the role of the
complementary strand of the first and second stem-loops of IRES in RNA
synthesis in vitro. This domain perfectly overlaps with
those identified in the HCV replicon system in vivo
(35).
 |
EXPERIMENTAL PROCEDURES |
Recombinant HCV RdRp--
HCV NS5B protein truncated by 21 C-terminal amino acids with a His6 tag was expressed in
Spodoptera frugiperda (Sf)-21AE cells and purified as
described previously (26). Purified HCV RdRp was stored at
25 °C
in the presence of 50% glycerol.
RNA Templates--
RNA templates designed from the complementary
sequences of HCV IRES (cIRES) were synthesized with a MEGAscript T7 RNA
polymerase kit (Ambion) (Fig. 1). The DNA
templates were produced by PCR using the primer pairs listed in Table
I. The sequence UGGC was added to the 3'
terminus of all the templates. The DNA templates were removed by
digestion with DNase I after in vitro transcription, and all
transcripts were purified by 6% PAGE, 7 M urea for use as
the templates of in vitro transcription by HCV RdRp,
followed by successive phenol-chloroform extraction and ethanol
precipitation. These RNA templates were resuspended in RNase-free water
and stored at
80 °C until used.

View larger version (38K):
[in this window]
[in a new window]
|
Fig. 1.
Model RNA templates derived from the
complementary strand of IRES. Structure and part of the sequence
of model RNA templates derived from the complementary strand of IRES.
The secondary structure of cSL1 and cSL2 is predicted by mFold. That of
cSL3 and cSL4 is drawn as a mirror of that of IRES because mFold
predicted 17 patterns for their secondary structure and it has yet to
be determined (36, 37). The designation of the model templates
indicates the name of the complementary sequences of the stem-loop
structure of IRES. All the templates have UGGC (underlined)
at their 3' terminus. The 3' termini of SL234-1D, SL234, SL34-S, SL34,
SL4, and SL0 start from the position marked by arrowtails
(A). In SL34-SS, 6 Gs (bold) are substituted by 6 As (bold) of SL34-S (B). Templates carrying only
cSL1 and cSL2 (SL12, SL12-1S, and SL12-1LD) are designed as an
internal deletion of cIRES (C, D, and
E). The 3' terminus of SL2 starts from the position marked
by an arrowtail (C). In SL1234-1S and SL12-1S,
the GC stem sequences are substituted with AU (D). In
SL1234-1LD and SL12-1LD, the AAUC sequence of the loop structure is
substituted with A (E).
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Sequences of the primers used in this study
The T7 polymerase promoter sequence is shown in bold (TK-1 and TK-2).
The mutated nucleotides are shown in italics (TK-10 to TK-12). An extra
GCCA sequence was added to the 3' terminus of the RNA templates (TK-4
to TK-13).
|
|
Transcription in Vitro--
Unless otherwise indicated, HCV RdRp
activity was measured in 50 µl of standard transcription buffer,
TxG(+) (20 mM Tris/HCl (pH 8.0), 100 mM KCl,
2.5 mM MnCl2, 50 µM ATP, 50 µM CTP, 5 µM UTP, 0.5 mM GTP,
0.185 Mbq of [
-32P]UTP, 10 pmol of RNA template, 25 µg/ml actinomycin D, 5 units of human placental RNase inhibitor
(Nacalai Tesque, Japan), 1 mM DTT, and 10 pmol of NS5B).
For the single-round transcription assay, the reaction mixture without
nucleotides was preincubated with 50 or 500 µM GTP at
29 °C for 30 min. Then 0.2 mg/ml heparin (Wako Chemicals, Japan) was
added to the mixture, followed by ATP, CTP, and UTP, respectively, and
the reaction mixture was further incubated at 29 °C for an
additional 90 min. The reaction was stopped by extraction of 150 µl
of Sepasol RNA II (Nacalai Tesque, Japan) and 40 µl of chloroform.
[32P]UMP-labeled RNA was precipitated with the equal
volume of 2-propanol. The radiolabeled RNA was washed with 70%
ethanol, dried, and resuspended in formamide dye loading buffer and
analyzed by electrophoresis on a 6% PAGE containing 7 M
urea. The radioactivity of the transcribed RNA was measured with a
BAS-2000 image analyzer (Fuji Film), and the amount of transcribed RNA
was calculated from the amount of UMP in the transcripts. Each value
was calculated from the average of at least three independent assays.
Gel Shift Assay--
cIRES, SL234-1D, SL234, SL34, SL4, and SL0
were transcribed in vitro in 40 mM Tris/HCl (pH
7.6), 10 mM DTT, 0.5 mM each of ATP, CTP, and
GTP, 50 mM UTP, 50 µCi of UTP (Amersham Biosciences), 10 µg of DNA template, 20 units of human placental RNase inhibitor, and
50 units of T7 RNA polymerase (Toyobo, Japan) at 37 °C for 4 h.
The transcribed RNA was purified by electrophoresis on a 6% PAGE
containing 7 M urea. [32P]UMP-labeled RNA
templates (20,000 cpm) were incubated in 20 µl of 20 mM
Tris/HCl (pH 8.0), 100 mM KCl, 2.5 mM
MnCl2, 5 units of human placental RNase inhibitor, 1 mM DTT, 2 mg/ml yeast tRNA (Roche Molecular Biochemicals),
and 3.2 pmol NS5B with or without 0.5 mM GTP on ice for
1 h. Then 4 µl of DNA sample buffer (0.002% bromphenol blue,
0.002% xylene cyanol, and 50% glycerol) was added, and the mixture
was analyzed by electrophoresis on 0.8% agarose gel (Nacalai Tesque,
Japan) in TAE buffer (40 mM Tris/HCl, 20 mM
acetic acid, and 1 mM EDTA). After the electrophoresis the gel was dried and analyzed with the BAS-2000 image analyzer. For the
competition assay, 1, 10, 100, and 1000 pmol of non-labeled cIRES,
SL234-1D, SL234, SL34, SL4, SL0, 3NTR, and XREG (26) were incubated in
the binding reaction mixture with [32P]UMP-labeled cIRES
(20,000 cpm). For the detection of the HCV RdRp protein, the agarose
gel was stained with 0.2% Coomassie Brilliant Blue R-250 (Wako
Chemicals, Japan) for 1 h and destained with 50% methanol and 5%
acetic acid.
 |
RESULTS |
Single-round Transcription--
First of all, the concentration of
heparin for the single-round transcription was determined (Fig.
2A). HCV RdRp and cIRES template
(10 pmol each) were treated with 3.1, 6.25, 12.5, 25, 50, 100, and 200 µg/ml of heparin after preincubation with 50 µM (G(
))
or 0.5 mM GTP (G(+)) in 20 mM Tris/HCl (pH
8.0), 100 mM KCl, 2.5 mM MnCl2, 25 µg/ml actinomycin D, and 5 units of human placental RNase inhibitor
at 29 °C for 30 min. Then 50 µM ATP, 50 µM CTP, 5 µM UTP, and 0.185 Mbq of
-[32P]UTP were added and incubated for an additional
90 min. The RdRp activity with more than 0.2 mg/ml heparin was about
20% that without heparin and did not drop below 20% even when more
heparin was added. Next, the time course with 0.2 mg/ml heparin was
examined (Fig. 1B). Under these conditions, the accumulation
of transcribed RNA continued for 90 min and reached a plateau. Thus,
0.2 mg/ml heparin was used for the single-round transcription assay of
HCV RdRp.

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 2.
Determination of heparin concentration for
single-round transcription. A, 10 pmol of cIRES was
preincubated in 20 mM Tris/HCl (pH 8.0), 100 mM
KCl, 2.5 mM MnCl2, 50 µM (G( ))
or 0.5 mM GTP (G(+)), 25 µg/ml actinomycin D, 5 units of
human placental RNase inhibitor (Nacalai Tesque, Japan), 1 mM DTT, and 10 pmol NS5B at 29 °C for 30 min. Then
heparin (0, 3.1, 6.3, 12.5, 25, 50, 100, and 200 µg/ml), 50 µM ATP, 50 µM CTP, and 5 µM
UTP, and 0.185 Mbq [ -32P]UTP were added successively,
and the reaction mixture was further incubated for 90 min.
B, the time course of single-round transcription with 0.2 mg/ml heparin in TxG(+) was measured until 120 min. Inset,
the autoradiogram of 6% PAGE, 7 M urea. The position of
the template-sized transcribed products is indicated by the
arrowhead.
|
|
Effect of Stem-loop Structures on Transcription in
Vitro--
First, the activity of deletion mutant templates for
stem-loop structures was measured by the single-round transcription
assay because the initiation activity could be accurately measured with this assay (Figs. 1 and 3). Under de
novo initiation by 0.5 mM GTP, the template activity
of SL234-1D, SL234, SL34, SL4, and SL0 was 74.8, 88.2, 34.2, 27.9, and
9.7% that of cIRES, respectively (Fig. 3D). There was no
significant difference among cIRES, SL234-1D, and SL234. However,
there was a big decrease in activity between SL234 and SL34. Without
the initiation, far less RNA was synthesized de novo, and
there was little difference among them.

View larger version (75K):
[in this window]
[in a new window]
|
Fig. 3.
Analysis of deletion mutants of stem-loop
structures. The template activity of cIRES, SL234-1D, SL234,
SL34, SL4, and SL0 was measured in 50 µl of the standard
transcription buffer TxG(+) (A and B, G(+) in
C and D) or TxG( ) (G( ) in C and
D) under the multiround (A and C) and
the single round (B and D) condition. After
electrophoresis on a 6% PAGE containing 7 M urea, the
radioactivity of each template-sized transcript was measured with a BAS
image analyzer (A and B), and the amount of
synthesized RNA was calculated (C and D). Average
values with the S.D. (error bar) of the relative template
activity were calculated from at least three independent measurements.
The position of the template-sized transcribed products of cIRES
(1), SL234-1D (2), SL234 (3), SL34
(4), SL4 (5) and SL0 (6) is indicated
at the right (A and B). Short
additional transcripts from the first four templates are indicated by a
star.
|
|
Next, in order to analyze the effect of the stem-loop structures and
sequences between SL234 and SL34 on de novo transcription more precisely, single-round transcriptions using SL34-S, SL1234-1S, SL1234-1LD, and SL34-SS were performed (Figs. 1 and 5A).
Again, the sequence UGGC was added to the 3' terminus of each template. The amount of RNA synthesized from 10 pmol of cIRES, SL234-1D, SL234, SL34, SL4, SL0, SL34-S, SL1234-1S, SL1234-1LD, and SL34-SS was
8.06, 6.03, 7.11, 2.76, 2.25, 0.78, 3.90, 4.49, 9.22, and 5.16 fmol, respectively.
Several bands smaller than the template were found among the
transcripts from cIRES, SL234-1D, SL234, and SL34 (Fig. 3,
A and B). Additional transcripts were also found
in SL34-S, SL1234-1S, SL1234-1LD, and SL34-SS (Fig. 5A).
However, no additional bands were found in SL4 and SL0. From the
pattern and size of the transcripts, we concluded that they were
produced by early termination. From the size of the two major
additional transcripts estimated from PAGE (Fig. 3, *1 and
*2), transcription terminated in bulge *1 and
*2 of cSL3, respectively (Fig. 1). Until this experiment, we
only calculated the transcripts of template size, excluding those
derived from early termination.
To compare the effect of cSL1 and cSL2, we designed templates without
early termination as follows: SL12, SL2, SL12-1S, SL12-1LD, and
SL0+SL1 (Fig. 1 and Fig. 5, B and C). From these
templates few additional transcripts were obtained. The transcripts of
SL2, SL12-1S, and SL12-1LD were 165.5, 258.4, and 91.7% the level of SL12 (Fig. 5B). When cSL1 was added to SL0
(SL0+SL1), the transcripts were 69.0% the level without
cSL1 (SL0) (Fig. 1C).
Effect of Stem-loop Structures on Binding to HCV
RNA-dependent RNA Polymerase--
The same deletion mutant
templates were examined for binding to HCV RdRp by gel shift assay
(Fig. 4). The relative binding ratio was
calculated after correcting for the number of UMP in the probes. The
relative binding ratio with 0.5 mM GTP was 100, 74, 83, 46, 58, and 60% whereas that without GTP was 178, 89, 79, 89, 58, and
60%, for cIRES, SL-234-1D, SL234, SL34, SL4, and SL0, respectively.
For the competition assay, HCV RdRp and radiolabeled cIRES were
incubated with 1, 10, 100, and 1000 pmol of unlabeled cIRES, SL234,
SL34, SL34-S, SL4, SL0, 3NTR, and XREG, respectively. One pmol
of cIRES and SL234-1D inhibited the binding of cIRES with HCV RdRp.
One pmol of 3NTR almost inhibited the binding as well. Ten pmol of
SL234, SL34, SL34-S, and XREG inhibited the gel shift with cIRES. From
these results, cSL2 is concluded important for binding with HCV RdRp
especially in 0.5 mM GTP.

View larger version (72K):
[in this window]
[in a new window]
|
Fig. 4.
RdRp binding activity of stem-loop structures
of the complementary strand of IRES. A, RdRp binding
activity. [32P]UMP-labeled (20,000 cpm) cIRES, SL234-1D,
SL234, SL34, SL4, and SL0 were incubated with or without 0.5 mM GTP. The relative binding ratio to that of cIRES with
0.5 mM GTP was calculated after correcting for the number
of UMP in the probes and is indicated on the autoradiogram.
B, competition assay. [32P]UMP-labeled cIRES
(20,000 cpm) and HCV RdRp (3.2 pmol) were incubated with 1, 10, 100, and 1000 pmol of the indicated unlabeled competitor RNA (Fig. 1) (26).
C, detection of HCV RdRp protein in the same 0.8% agarose
gel by Coomassie Brilliant Blue R-250 (lane 2). The
position of HCV RdRp is indicated by arrows.
|
|
 |
DISCUSSION |
The HCV RNA genome contains conserved 5'- and 3'-UTRs (8-12). As
in the case of Flaviviridae family viruses, the 3'-terminal X-region is
expected to play an important role in the synthesis of the minus
strand, and the complementary strand of IRES is expected to serve as
the origin for plus strand synthesis in genome replication (4). The
complementary strand of IRES may also work as a promoter of
transcription. Mutations in IRES also affected the replication of
genomic RNA (35). The reason for this may be that the mutation in the
3' terminus of the complementary strand (cIRES) affected the
replication and transcription. Both termini of the viral genomic RNA
have stem-loop secondary structures. The 3' termini of both the plus
and minus strands of genomic RNA are able to serve as templates for
RdRp in vitro (16) The complementary sequences of IRES had
the highest template activity for de novo RNA synthesis in vitro (26, 34). However, activity for the de
novo synthesis of RNA in vitro by RdRp in the X region
was very weak (26). Therefore, we determined the promoter/origin
structure of the complementary strand of IRES.
In the multiround transcription system, the products from short
templates were sometimes larger than those from long ones. To compare
the initiation activity, we established a de novo
single-round transcription system using 0.2 mg/ml heparin to treat HCV
RdRp and templates followed by preincubation with 0.5 mM
GTP (Fig. 2). Because HCV RdRp prefers a cytidine at the 3' terminus
and interacts with GTP (28, 30, 32, 33), all the templates are designed
to have UGGC at the 3' terminus (Figs. 1 and
5). We have temporally used the secondary
structure of cIRES as a mirror image of that of IRES in Fig. 1
until it is determined experimentally (36, 37).

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 5.
Determination of the promoter/origin
structure of the complementary strand of IRES. Representative
autoradiograms are shown, and the amount of synthesized RNA
(A) and the relative template activity of cIRES and its
mutants (B and C) were measured by the
single-round transcription assay of de novo RNA synthesis in
TxG(+). The average and the S.D. of synthesized RNA were calculated
from the autoradiogram of three independent experiments. The structure
of SL0+SL1 is indicated in the inset (C).
|
|
Because the transcription activity following the treatment with 0.5 mM GTP decreased markedly when cSL2 was deleted, cSL2 was
important for de novo initiation (Fig. 3D).
However, the activity of SL1234-1S was also half of that of cIRES.
Because the Tm of the UA stem was 12 °C, a stem
structure might not form in the reaction at 29 °C. A comparison of
the activity of cIRES, SL1234-1D, SL1234-1S, and SL1234-1LD
indicated the complicated secondary structure of the template, although
cSL2 and the stem of cSL1 may affect the structure of the
promoter/origin. The sequence between cSL2 and cSL3 could also affect
the activity. The seven Gs, which exist between cSL2 and cSL3, did not
affect the activity. From a comparison of the activity of SL32-S,
SL34-SS, and SL34, the length of the single stranded sequence at the 3'
terminus was confirmed important as reported previously (26).
In this series of experiments, we calculated the product amount
from only the template-sized bands. Additional products were transcribed from the templates containing cSL3 (Figs. 2 and 5). We
measured the size of the products of template size and smaller (Fig. 3, *1 and *2). By comparing their
size with that of the templates, the products *1 and *2 were identified
as early termination products from the templates. The positions of
possible termination sites are mapped in the bulges of cSL3 (Fig. 1).
There is a triple helical structure in IRES corresponding to bulge *1,
and a complex stem-loop in the stem structure of stem-loop 3 corresponding to bulge *2. We predict a strong secondary structure for
these sequences in cIRES. The results and the prediction of secondary
structure by mFold (bioinfo.math.rpi.edu/~zukerm/) (38, 39), which
predicted too many to be shown here, suggest a complicated secondary
structure of cIRES. The results obtained with deletion mutants of
stem-loop structures of cIRES were difficult to interpret. The cIRES
sequence may make complicated stem-loop structures which interact
with each other. Therefore, we decided to design a simpler template.
Because we could not predict the secondary structure of cIRES but
wanted to elucidate the role of cSL1 and cSL2 in the template activity,
we constructed templates carrying only cSL1 and cSL2 (SL2) to exclude
early termination (Fig. 5B). In this experiment, the
activity of SL12-1S was more than twice that of SL12 but that of
SL12-1LD was similar to the activity of SL2. Because the
Tm of the UA stem in Fig. 1D was
12 °C, a stem structure might not form in the reaction at 29 °C.
The stem structure of cSL1 could inhibit the activity. The sequence of
the cSL1 loop did not affect the activity. Because the results from the
templates carrying mutant sequences of cSL1 were not conclusive, we
made additional templates carrying simple structures. When cSL1 was
added to SL0 (SL0+SL1), the amount of product decreased, confirming
that cSL1 was a negative element (Fig. 5C). cSL1 was always
identified as shown in Fig. 1 when the secondary structure of the
templates was predicted by mFold (data not shown). When cSL1 exists,
the length of the 3' single-stranded RNA is only four nucleotides, too
short to initiate the reaction because at least a five-nucleotide single-stranded RNA is required for initiation (31, 40-43).
We demonstrated that HCV RdRp bound to the 3' terminus of the
complementary strand RNA as well as that of the positive strand RNA
(14). Gel shift assay indicates that cSL2 is also important for the
binding of HCV RdRp especially with 0.5 mM GTP (Fig.
4A). Without 0.5 mM GTP, the template-RdRp
interaction was enhanced, and SL34 also bound to RdRp effectively. The
RdRp binding activity of cSL2 was similar to that of the poly(U/C)
tract in the 3' terminus of HCV genome RNA (Fig. 4B). RdRp
could also bind to other stems or sequences although the binding was
weaker than that of cIRES, SL234-1D, and SL234. Considering the
results of transcription and RdRp binding, cSL2 would be a positive
element of the promoter/origin structure because it binds specifically
to RdRp with 0.5 mM GTP. 0.5 mM GTP may give
specificity to the binding of RdRp to cSL2.
Although we did not show the results, copy-back products became
apparent without 0.5 mM GTP preincubation even in
single-round transcription. The mechanism of switching from de
novo initiation with 0.5 mM GTP preincubation to
copy-back initiation remains to be resolved.
Fig. 6 shows the proposed scheme of
initiation from the 3' terminus of the complementary strand of IRES.
HCV RdRp binds to cSL2. HCV RdRp can start with single-stranded 3'
termini (17, 31). However, the 3' single-stranded sequences of cIRES
are only four nucleotides long and are too short to reach the active site of RdRp because of the
-hairpin structure (30, 31, 42), so they
cannot initiate transcription efficiently. NS3 helicase binds to cSL1
(44) and may relax the stem-loop structure to bring the 3' terminus to
the RdRp active site so that RdRp interacts with GTP. NS3 interacts
with RdRp (45). In both cases, NS3 and HCV RdRp are expected to form a
transcription and replication initiation complex. Recently, HS5A was
found to bind RdRp and modulate its activity (46). We have demonstrated
that cSL2 played an important role in the initiation of transcription
and replication of the HCV genome by interacting with RdRp. High
concentrations of GTP may give specificity to the interaction between
RdRp and template. The HCV initiation complex needs to be reconstituted in vitro using purified RdRp and NS3.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Possible scheme for initiation from the
complementary strand of IRES. First, HCV RdRp binds to cSL2 of the
complementary strand of IRES. At this point, the 3' end of the
templates did not reach to the catalytic center of the RdRp when cSL1
formed because a 5-nucleotide-long single-stranded RNA end is required
to reach the catalytic center (31, 42). NS3 helicase binds to cSL1
(44), and open its stem and the 3' terminus extend to reach the
catalytic center (45). HCV RdRp continues to synthesize RNA and moves
to the 5' end of the RNA template.
|
|
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Dept. of Virology,
Kurume University School of Medicine, 67 Asahimachi, Kurume, Fukuoka
830-0011, Japan. Tel.: 81-942-31-7549; Fax: 81-942-32-0903; E-mail:
ttoyoda@med.kurume-u.ac.jp.
Published, JBC Papers in Press, May 30, 2002, DOI 10.1074/jbc.M201251200
 |
ABBREVIATIONS |
The abbreviations used are:
HCV, hepatitis C
virus;
UTR, untranslated region;
IRES, internal ribosome entry site;
RdRp, RNA-dependent RNA polymerase;
DTT, dithiothreitol;
cIRES, complementary strand IRES.
 |
REFERENCES |
| 1.
|
van Regenmortel, M. H. V.,
Fauquet, C. M. F.,
Bishop, D. H. L.,
Carstens, E. B.,
Estes, M. K.,
Lemon, S. M.,
Maniloff, J.,
Mayo, M. A.,
McGeoch, D. J.,
Pringle, C. R.,
and Wickner, R. B.
(2000)
Virus Taxonomy, Seventh Report of the International Committee on Taxonomy of Viruses
, pp. 872-878, Academic Press, San Diego
|
| 2.
|
Alter, M. J. H.
(1997)
Hepatology
26,
62-65[CrossRef]
|
| 3.
|
Bartenschlager, R.
(1997)
Antiviral Chem. Chemother.
8,
281-301
|
| 4.
|
Lindenbach, B. D.,
and Rice, C. M.
(2001)
in
Flaviviridae: The Viruses and Their Replication
(Fields, B. N.
, Knipe, D. M.
, and Howly, P. M., eds), 4th Ed.
, pp. 991-1042, Lippincott-Raven Publishers, Philadelphia, NY
|
| 5.
|
Grakoui, A.,
McCourt, D. W.,
Wychowski, C.,
Feinstone, S. M.,
and Rice, C. M.
(1993)
J. Virol.
67,
2832-2843[Abstract/Free Full Text]
|
| 6.
|
Matsuura, Y.,
and Miyamura, T.
(1993)
Semin. Virol.
4,
297-304[CrossRef]
|
| 7.
|
Tomei, L.,
Failla, C.,
Santolini, E., De,
Francesco, R.,
and La Monica, N.
(1993)
J. Virol.
67,
4017-4026[Abstract/Free Full Text]
|
| 8.
|
Fukushi, S.,
Katayama, K.,
Kurihara, C.,
Ishiyama, N.,
Hoshino, F. B.,
Ando, T.,
and Oya, A.
(1994)
Biochem. Biophys. Res. Commun.
199,
425-432[CrossRef][Medline]
[Order article via Infotrieve]
|
| 9.
|
Kohara, T. K.,
Iizuka, N.,
Kohara, M.,
and Nomoto, A.
(1992)
J. Virol.
66,
1476-1483[Abstract/Free Full Text]
|
| 10.
|
Lemon, S. H.,
and Honda, M.
(1997)
Semin. Virol.
8,
274-288[CrossRef]
|
| 11.
|
Tanaka, T.,
Kato, N.,
Cho, M.-J.,
Sugiyama, K.,
and Shimotohno, K.
(1996)
J. Virol.
70,
3307-3312[Abstract]
|
| 12.
|
Tanaka, T.,
Kato, N.,
Cho, M.-J.,
and Shimotohno, K.
(1995)
Biochem. Biophys. Res. Commun.
215,
744-749[CrossRef][Medline]
[Order article via Infotrieve]
|
| 13.
|
Yanagi, M., St,
Claire, M.,
Emerson, S. U.,
Purcell, R. H.,
and Bukh, J.
(1999)
Proc. Natl. Acad. Sci. U. S. A.
96,
2291-2295[Abstract/Free Full Text]
|
| 14.
|
Cheng, J.-C.,
Chang, M.-F.,
and Chang, S. C.
(1999)
J. Virol.
73,
7044-7049[Abstract/Free Full Text]
|
| 15.
|
Kolykhalov, A. A.,
Mihalik, K.,
Feinstone, S. M.,
and Rice, C. M.
(2000)
J. Virol.
74,
2046-2051[Abstract/Free Full Text]
|
| 16.
|
Oh, J. W.,
Ito, T.,
and Lai, M. M.
(1999)
J. Virol.
73,
7694-7702[Abstract/Free Full Text]
|
| 17.
|
Oh, J. W.,
Sheu, G. T.,
and Lai, M. M.
(2000)
J. Biol. Chem.
275,
17710-17717[Abstract/Free Full Text]
|
| 18.
|
Behrens, S.,
Tomei, L.,
and De Francesco, R.
(1996)
EMBO J.
15,
12-22[Medline]
[Order article via Infotrieve]
|
| 19.
|
Hagedorn, C. H.,
van Beers, E. H.,
and De Staaercke, C.
(2000)
Curr. Top. Microbiol. Immunol.
242,
225-260[Medline]
[Order article via Infotrieve]
|
| 20.
|
Lesburg, C. A.,
Radfar, R.,
and Weber, P. C.
(2000)
Curr. Opin. Investig. Drugs
1,
289-296[Medline]
[Order article via Infotrieve]
|
| 21.
|
Lohmann, V.,
Köner, F.,
Herian, U.,
and Bartenschlager, R.
(1997)
J. Virol.
71,
8416-8428[Abstract]
|
| 22.
|
Lohmann, V.,
Roos, A.,
Köner, F.,
Herian, U.,
and Bartenschlager, R.
(2000)
J. Viral Hep.
7,
167-174
|
| 23.
|
Lohmann, V.,
Roos, A.,
Köner, F.,
Koch, J. O.,
and Bartenschlager, R.
(1998)
Virology
249,
108-118[CrossRef][Medline]
[Order article via Infotrieve]
|
| 24.
|
Sun, X.-L.,
Johnson, R. B.,
Hockman, M. A.,
and Wang, Q. M.
(2000)
Biochem. Biophys. Res. Commun.
268,
798-803[CrossRef][Medline]
[Order article via Infotrieve]
|
| 25.
|
Ferrari, E.,
Wright-Minogue, J.,
Fang, J. W. S.,
Baroudy, B. M.,
Lau, J. Y. N.,
and Hong, Z.
(1999)
J. Virol.
73,
1649-1654[Abstract/Free Full Text]
|
| 26.
|
Kashiwagi, T.,
Hara, K.,
Kohara, M.,
Kohara, K.,
Iwahashi, J.,
Hamada, N.,
Honda, H.,
and Toyoda, T.
(2002)
Biochem. Biophys. Res. Commun.
250,
1188-1194
|
| 27.
|
Yamashita, T.,
Kaneko, S.,
Shirota, Y.,
Qin, W.,
Nomura, T.,
Kobayashi, K.,
and Murakami, S.
(1998)
J. Biol. Chem.
273,
15479-15486[Abstract/Free Full Text]
|
| 28.
|
Luo, G.,
Hamatake, R. K.,
Mathis, D. M.,
Racela, J.,
Rigat, K. L.,
Lemm, J.,
and Colonno, R. J.
(2000)
J. Virol.
74,
851-863[Abstract/Free Full Text]
|
| 29.
|
Zhong, W.,
Uss, A. S.,
Ferrari, E. J.,
Lau, Y. N.,
and Hong, Z.
(2000)
J. Virol.
74,
2017-2022[Abstract/Free Full Text]
|
| 30.
|
Hong, Z.,
Cameron, C. E.,
Walker, M. P.,
Castro, C.,
Yao, N.,
Lau, J. Y. N.,
and Zhong, W.
(2001)
Virology
285,
6-11[CrossRef][Medline]
[Order article via Infotrieve]
|
| 31.
|
Zhong, W.,
Ferrari, E.,
Lesburg, C. A.,
Maag, D.,
Ghosh, S. K. B.,
Cameron, C. E.,
Lau, J. Y. N.,
and Hong, Z.
(2000)
J. Virol.
74,
9134-9143[Abstract/Free Full Text]
|
| 32.
|
Kao, C. C.,
Yang, X.,
Kline, A.,
Wang, Q. M.,
Barket, D.,
and Heinz, B. A.
(2000)
J. Virol.
74,
11121-11128[Abstract/Free Full Text]
|
| 33.
|
Lohmann, V.,
Overton, H.,
and Bartenschlager, R.
(1999)
J. Biol. Chem.
274,
10807-10815[Abstract/Free Full Text]
|
| 34.
|
Reigadas, S.,
Ventura, M.,
Sarih-Cottin, L.,
Castroviejo, M.,
Litvak, S.,
and Astier-Gin, T.
(2001)
Eur. J. Biochem.
268,
5857-5867[Medline]
[Order article via Infotrieve]
|
| 35.
|
Friebe, P.,
Lohnmann, V.,
Krieger, N.,
and Bartenschlager, R.
(2000)
J. Virol.
75,
12047-12057
|
| 36.
|
Honda, M.,
Beard, M. R.,
Ping, L. H.,
and Lemon, S. M.
(1999)
J. Virol.
73,
1165-1174[Abstract/Free Full Text]
|
| 37.
|
Lukavsky, P. J.,
Otto, G. A.,
Lancaster, A. M.,
Sarnow, P.,
and Puglisi, J. D.
(2000)
Nat. Struct. Biol.
7,
1105-1110[CrossRef][Medline]
[Order article via Infotrieve]
|
| 38.
|
Mathews, D. H.,
Sabina, J.,
Zuker, M.,
and Turner, D. H.
(1999)
J. Mol. Biol.
288,
911-940[CrossRef][Medline]
[Order article via Infotrieve]
|
| 39.
|
Zuker, M.,
Mathews, D. H.,
and Turner, D. H.
(1999)
in
RNA Biochemistry and Bio/Technology
(Barciszewski, J.
, and Clark, B. F. C., eds)
, pp. 11-43, Kluwer Academic Publishers, Norwell, MA
|
| 40.
|
Ago, H.,
Adachi, T.,
Yoshida, A.,
Yamamoto, M.,
Habuka, N.,
Yatsunami, K.,
and Miyano, M.
(2000)
Structure
7,
1417-1426
|
| 41.
|
Bressanelli, S.,
Tomei, L.,
Roussel, A.,
Vitale, R. L.,
Mathieu, M., De,
Francesco, R.,
and Rey, F. A.
(2000)
Proc. Natl. Acad. Sci. U. S. A.
96,
13034-13039
|
| 42.
|
Butcher, S. J.,
Grimes, J. M.,
Makeyev, E. V.,
Bamford, D. H.,
and Stuart, D. I.
(2001)
Nature
410,
235-240[CrossRef][Medline]
[Order article via Infotrieve]
|
| 43.
|
Lesburg, C. A.,
Cable, M. B.,
Ferrari, E.,
Hong, Z.,
Mannarino, A. F.,
and Weber, P. C.
(1999)
Nat. Struct. Biol.
6,
937-943[CrossRef][Medline]
[Order article via Infotrieve]
|
| 44.
|
Banerjee, R.,
and Dasgupta, A.
(2001)
J. Virol.
75,
1708-1721[Abstract/Free Full Text]
|
| 45.
|
Ishido, S.,
Fujita, T.,
and Hotta, H.
(1998)
Biochem. Biophys. Res. Commun.
244,
35-40[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Shirota, Y.,
Luo, H.,
Quin, W.,
Kaneko, S.,
Yamashita, T.,
Kobayashi, K.,
and Murakami, S.
(2002)
J. Biol. Chem.
277,
2132-2137[Abstract/Free Full Text]
|
Copyright © 2002 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
M. Binder, D. Quinkert, O. Bochkarova, R. Klein, N. Kezmic, R. Bartenschlager, and V. Lohmann
Identification of Determinants Involved in Initiation of Hepatitis C Virus RNA Synthesis by Using Intergenotypic Replicase Chimeras
J. Virol.,
May 15, 2007;
81(10):
5270 - 5283.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. T. Ranjith-Kumar, R. T. Sarisky, L. Gutshall, M. Thomson, and C. C. Kao
De Novo Initiation Pocket Mutations Have Multiple Effects on Hepatitis C Virus RNA-Dependent RNA Polymerase Activities
J. Virol.,
November 15, 2004;
78(22):
12207 - 12217.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2002 by the American Society for Biochemistry and Molecular Biology.